BE516687A - - Google Patents
Info
- Publication number
- BE516687A BE516687A BE516687DA BE516687A BE 516687 A BE516687 A BE 516687A BE 516687D A BE516687D A BE 516687DA BE 516687 A BE516687 A BE 516687A
- Authority
- BE
- Belgium
- Prior art keywords
- contrast agent
- alcohol
- suspension
- acid
- toxic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE516687A true BE516687A (2) |
Family
ID=153807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE516687D BE516687A (2) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE516687A (2) |
-
0
- BE BE516687D patent/BE516687A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0233106B1 (fr) | (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique | |
| EP1347950A1 (fr) | Derives de l'acide 4-hydroxybutano que et de son homologue superieur comme ligands des recepteurs du gamma-hydroxybutyrate (ghb) compositions pharmaceutiques les contenant et utilisations pharmaceutiques | |
| CA1204445A (fr) | Procede de preparation de nouveaux derives de la 1,3- dihydro 4-(1-hydroxy 2-aminoethyl) 2h-indol-2-one | |
| EP0015038A1 (fr) | Composition pharmaceutique comprenant un dérivé de diphénylhydantoine, dérivés mis en oeuvre et leur préparation | |
| EP0133103B1 (fr) | Benzyl-phényl-osides, procédé de préparation et utilisation | |
| CA2071983C (fr) | Derive de la beta-phenylisoserine, sa preparation et son emploi | |
| FR2491761A1 (fr) | Derives de l'adenosine a activite anti-inflammatoire et analgesique et compositions therapeutiques qui les contiennent en tant que principe actif | |
| BE516687A (2) | ||
| FR2522658A1 (fr) | Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation | |
| FR2503149A1 (fr) | Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques | |
| CA1298301C (fr) | Benzamides, leur procede d'obtention et leurs applications therapeutiques | |
| EP0374029B1 (fr) | Application de benzamides substitués comme gastromoteurs | |
| CA1076117A (fr) | Procede d'obtention de nouveaux ethers aryliques et les produits en resultant | |
| FR2503150A1 (fr) | Mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques | |
| EP0384088B1 (fr) | La (+) 1-[(3,4,5-triméthoxy) benzyloxyméthyl]-1-phényl-N,N-diméthyl-n-propylamine, son procédé de préparation et son application en thérapeutique | |
| CH646146A5 (fr) | Derive du 1alpha,25-dihydroxy cholecalciferol et son procede de preparation. | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| CA2029334A1 (fr) | Derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| BE499168A (2) | ||
| FR2583047A1 (fr) | Procede de preparation de derives du 4-phenylpropyl indole, et intermediaires | |
| CH628321A5 (en) | Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives | |
| MC1069A1 (fr) | Derives de l'acide 5-acetylsalicylique et medicament contenant ces substances | |
| FR2467846A1 (fr) | Nouveaux b hydroxy esters de piperidyle | |
| BE521451A (2) | ||
| BE697967A (2) |